Key result
Regulatory burden from recent changes to research governance is obstructing high-quality clinical science.
Key points are not available for this paper at this time.
Design
Editorial
Highlights the negative impact of excessive regulatory burden on the conduct of high-quality clinical research.
Recent changes to research governance were intended to ensure that clinical trials are safe and effective. But Paul Stewart and colleagues argue that the regulatory burden is now obstructing high quality science
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2008) studied this question. Regulatory burden from recent changes to research governance is obstructing high-quality clinical science.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: